Upregulation of interleukin-8 and polarized epithelial expression of interleukin-8 receptor a in ovarian carcinomas

References

• Malik S, Balkwill F. Epithelial ovarian cancer: a cytokine propelled disease? Br J Cancer 1991; 64: 617–20
   PubMed Web of Science ®Google Scholar
• Ivarsson K, Runesson E, Sundfeldt K, Haeger M, Hedin L, Janson P O, et al. The chemotactic cytokine interleukin-8 - A cyst fluid marker for malignant epithelial ovarian cancer? Gynecol Oncol 1998; 71: 420–3
   Google Scholar
• Karasik A, Mensczer J, Pariente C, Kanety H. Insulin-like growth factor-I (IGF-1) and IGF-binding protein 2 are increased in cyst fluids of epithelial ovarian cancer. J Clin Endocrin Metab 1994; 78: 271–6
   PubMed Web of Science ®Google Scholar
• Runesson E, Boström E-K, Janson P O, Brännström M. The human preovulatory follicle is a source of the chemotactic cytokine interleukin-8. Mol Hum Reprod 1996; 2: 245–50
   PubMed Web of Science ®Google Scholar
• Koch A E, Polverini P J, Kunkel S L, Harlow L A, DiPietro L A, Elner V M, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798–801
   PubMed Web of Science ®Google Scholar
• Wolf M, Delgado M B, Jones S A, Dewald B, Clark-Lewis I, Baggiolini M. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2. Eur J Immunol 1998; 28: 164–70
   PubMed Web of Science ®Google Scholar
• Lee J, Horuk R, Rice G C, Bennett G L, Camerato T, Wood W I. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 1992; 267: 16283–7
   PubMed Web of Science ®Google Scholar
• Chuntharapai A, Kim K J. Regulation of the expression of IL-8 receptor A/B by IL-8: possible function of each receptor. J Immunol 1995; 155: 2587–94
   PubMed Web of Science ®Google Scholar
• Singh R K, Varney M L. Regulation of interleukin 8 expression in human malignant melanoma cells. Cancer Res 1998; 58: 1532–7
   PubMed Web of Science ®Google Scholar
• Galffy G, Mohammed K A, Dowling P A, Nasreen N, Ward M J, Antony V B. Interleukin 8: an autocrine growth factor for malignant mesothelioma. Cancer Res 1999; 59: 367–71
   PubMed Web of Science ®Google Scholar
• Green A R, Greeen V L, White M C, Speirs V. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumors. Int J Cancer 1997; 72: 937–41
   PubMed Web of Science ®Google Scholar
• Ferrer F A, Miller L J, Andrawis R I, Kurtzman S H, Alberts-En P C, Laudone V P, et al. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology 1998; 51: 161–6
   PubMed Web of Science ®Google Scholar
• Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yoko-Zaki H, et al. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 1998; 152: 93–100
   PubMed Web of Science ®Google Scholar
• Brew R, Southern S A, Flanagan B F, McDicken I W, Christmas S E. Detection of interleukin-8 mRNA and protein in human colorectal carcinoma cells. Eur J Cancer 1996; 32A: 2142–7
   PubMed Web of Science ®Google Scholar
• Miyamoto M, Shimizu Y, Okada K, Kashii Y, Higuchi K, Wanatabe A. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells. Cancer Immunol Immun-other 1998; 47: 47–57
   PubMed Web of Science ®Google Scholar
• Colasante A, Mascetra N, Brunetti M, Lattanzio G, Di-Odoro M, Caltagirone S, et al. Transforming growth factor bl, interleukin-8 and interleukin-1, in non-small cell lung cancer. Am J Respir Crit Care Med 1997; 156: 968–73
   PubMed Web of Science ®Google Scholar
• Miller L J, Kurtzman S H, Wang Y, Andersson K H, Lindqu-Ist R R, Kreutzer D L. Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res 1998; 18: 77–82
   PubMed Web of Science ®Google Scholar
• Richards B L, Eisma R J, Spiro J D, Lindquist R L, Kreutzer D L. Coexpression of interleukin-8 receptors in head and neck carcinoma. Am J Surg 1997; 174: 507–12
   PubMed Web of Science ®Google Scholar
• Arenberg D A, Kunkel S L, Polverini P J, Glass M, Burdick M D, Strieter R M. Inhibition of interleukin-8 reduces tu-morigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 1996; 97: 2792–802
   PubMed Web of Science ®Google Scholar
• Heniford B T, Edwards M J, Wilson M A, Klar E A, Doak K W, Miller F N. Interleukin-8 suppresses the toxicity and antitumor effect of interleukin-2. J Surg Res 1994; 56: 82–8
   PubMed Web of Science ®Google Scholar
• Wang J, Huang M, Lee P, Komanduri K, Sharma S, Chen G, et al. Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways. J Interferon Cytokine Res 1996; 16: 53–60
   PubMed Web of Science ®Google Scholar
• Merogi A J, Marrogi A J, Ramesh R, Robinson W R, Fermin C D, Freeman S M. Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas. Hum Pathol 1997; 28: 321–31
   PubMed Web of Science ®Google Scholar
• Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobay-Ashi Y, Lew W, et al. Molecular cloning of a human mono-cyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin-1 and tumor necrosis factor. J Exp Med 1988; 167: 1883–93
   PubMed Web of Science ®Google Scholar
• Belayet H M, Kanayama N, Khatun S, Sumimoto K, Ko-Bayashi T, Terao T. Binding of interleukin-8 to heparan sulphate enhances cervical maturation in rabbits. Mol Hum Reprod 1999; 5: 261–9
   PubMed Web of Science ®Google Scholar
• Webb L MC, Ehrengruber M U, Clark-Lewis I, Baggiolini M, Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci USA 1993; 90: 7158–62
   PubMed Web of Science ®Google Scholar
• Negus R PM, Stamp G WH, Hadley J, Balkwill F R. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokin-es. Am J Pathol 1997; 150: 1723–34
   PubMed Web of Science ®Google Scholar
• Schadendorf D, Möller A, Algermissen B, Worm M, Stich-Erling M, Czarnetzki B M. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 1993; 151: 2667–75
   PubMed Web of Science ®Google Scholar
• Youngs S J, Ali S A, Taub D D, Rees R C. Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 1997; 71: 257–66
   PubMed Web of Science ®Google Scholar
• Strieter R M, Polverini P J, Arenberg D A, Kunkel S L. The role of CXC chemokines as regulators of angiogenesis. Shock 1995; 4: 155–60
   PubMed Web of Science ®Google Scholar
• Smith D R, Polverini P J, Kunkel S L, Orringer M O, Whyte R I, Burdick M D, et al. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 1994; 179: 1409–15
   PubMed Web of Science ®Google Scholar
• Hollingsworth H C, Kohn E C, Steinberg S M, Rothenberg M L, Merino M J. Tumor angiogensis in advanced stage ovarian carcinoma. Am J Pathol 1995; 147: 33–41
   PubMed Web of Science ®Google Scholar
• Gawrychowski K, Skopi'nska-Rosewska E, Barcz E, Sommer E, Szaniawska B, Roskowska-Purska K, et al. Angiogenic activity and interleukin-8 content of human ovarian cancer ascites. Eur J Gynaecol Oncol 1998; XIX: 262–4
   Google Scholar
• Barcz E, Sommer E, Sokolnicka I, Gawrychowski K, Rosz-kowska-Purska K, Janik P, et al. The influence of theobromine on angiogenic activity and proangiogenic cytokine production of human ovarian cancer cells. Oncol Rep 1998; 5: 517–20
   PubMed Web of Science ®Google Scholar
• Dunlevy J R, Couchman J R. Interleukin-8 induces motile behavior and loss of focal adhesions in primary fibroblasts. J Cell Science 1995; 108: 311–21
   PubMed Web of Science ®Google Scholar